NCT04079920 Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients Status COMPLETED Phase N/A
NCT04076787 Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib Status COMPLETED Phase N/A
NCT04072952 A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT04071405 Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients Status COMPLETED Phase N/A
NCT04071158 A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS Status COMPLETED Phase PHASE2
NCT04070768 Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113 Status COMPLETED Phase PHASE1
NCT04065633 Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation Status COMPLETED Phase PHASE1
NCT04052204 Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT04051996 GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia Status TERMINATED Phase PHASE2
NCT04047121 A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis Patients Status COMPLETED Phase N/A
NCT04044430 Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer Status TERMINATED Phase PHASE1
NCT04044053 Relative Bioavailability Study of a Modified-Release Formulation of PF-06865571 in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT04040621 Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia Status TERMINATED Phase PHASE1
NCT04040192 A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT04039230 Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2